Blackhawk Growth Corp. (CNSX:BLR.CN) agreed to acquire MindBio Therapeutics Pty Ltd for AUD 9.1 million on August 30, 2021. Under the terms of transaction, Blackhawk Growth Corp. will issue 22,095,180 common shares to the existing shareholders of MindBio Therapeutics. Following completion of the acquisition, MindBio Therapeutics will form part of the Company’s existing portfolio of investments in the health care sector. MindBio Therapeutics’s existing board and directors will continue to retain responsibility for overseeing day-to-day operations, based upon an agreed budget. Completion of the acquisition remains subject to the satisfaction of customary closing conditions. Blackhawk Growth Corp. (CNSX:BLR) completed the acquisition of MindBio Therapeutics Pty Ltd on September 3, 2021.